Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |